| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.0071 | 1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |